AXL in cancer: a modulator of drug resistance and therapeutic target

被引：34
作者：
Tang, Yaoxiang [1 ]
Zang, Hongjing [1 ]
Wen, Qiuyuan [1 ]
Fan, Songqing [1 ]
机构：
[1] Cent South Univ, Xiangya Hosp 2, Dept Pathol, Changsha 410011, Hunan, Peoples R China
来源：
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | 2023年 / 42卷 / 01期
基金：
中国国家自然科学基金;
关键词：
AXL; Cancer; Drug resistance; Target therapy; Molecular mechanisms; RECEPTOR TYROSINE KINASE; EPITHELIAL-MESENCHYMAL TRANSITION; CELL LUNG-CANCER; ACQUIRED-RESISTANCE; BREAST-CANCER; DNA-DAMAGE; GAS6/AXL AXIS; EGFR-TKI; INHIBITION; PROMOTES;
D O I：
10.1186/s13046-023-02726-w
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AXL is a member of the TAM (TYRO3, AXL, and MERTK) receptor tyrosine kinases family (RTKs), and its abnormal expression has been linked to clinicopathological features and poor prognosis of cancer patients. There is mounting evidence supporting AXL's role in the occurrence and progression of cancer, as well as drug resistance and treatment tolerance. Recent studies revealed that reducing AXL expression can weaken cancer cells' drug resistance, indicating that AXL may be a promising target for anti-cancer drug treatment. This review aims to summarize the AXL's structure, the mechanisms regulating and activating it, and its expression pattern, especially in drug-resistant cancers. Additionally, we will discuss the diverse functions of AXL in mediating cancer drug resistance and the potential of AXL inhibitors in cancer treatment.
引用
收藏
页数：14
相关论文
共 113 条
  • [1] Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer
    Adam-Artigues, Anna
    Arenas, Enrique J.
    Martinez-Sabadell, Alex
    Braso-Maristany, Fara
    Cervera, Raimundo
    Tormo, Eduardo
    Hernando, Cristina
    Teresa Martinez, Maria
    Carbonell-Asins, Juan
    Simon, Soraya
    Poveda, Jesus
    Moragon, Santiago
    Zazo, Sandra
    Martinez, Debora
    Rovira, Ana
    Burgues, Octavio
    Rojo, Federico
    Albanell, Joan
    Bermejo, Begona
    Lluch, Ana
    Prat, Aleix
    Arribas, Joaquin
    Eroles, Pilar
    Miguel Cejalvo, Juan
    [J]. SCIENCE ADVANCES, 2022, 8 (20):
  • [2] Reprogramming the immunological microenvironment through radiation and targeting Axl
    Aguilera, Todd A.
    Rafat, Marjan
    Castellini, Laura
    Shehade, Hussein
    Kariolis, Mihalis S.
    Hui, Angela Bik-Yu
    Stehr, Henning
    von Eyben, Rie
    Jiang, Dadi
    Ellies, Lesley G.
    Koong, Albert C.
    Diehn, Maximilian
    Rankin, Erinn B.
    Graves, Edward E.
    Giaccia, Amato J.
    [J]. NATURE COMMUNICATIONS, 2016, 7
  • [3] Nanomedicine tactics in cancer treatment: Challenge and hope
    Al-Zoubi, Mazhar Salim
    Al-Zoubi, Raed M.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 174
  • [4] The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer
    Antony, Jane
    Tan, Tuan Zea
    Kelly, Zoe
    Low, Jeffrey
    Choolani, Mahesh
    Recchi, Chiara
    Gabra, Hani
    Thiery, Jean Paul
    Huang, Ruby Yun-Ju
    [J]. SCIENCE SIGNALING, 2016, 9 (448)
  • [5] AXL Receptor in Cancer Metastasis and Drug Resistance: When Normal Functions Go Askew
    Auyez, Almira
    Sayan, A. Emre
    Kriajevska, Marina
    Tulchinsky, Eugene
    [J]. CANCERS, 2021, 13 (19)
  • [6] Repression of AXL expression by AP-1/JNK blockage overcomes resistance to PI3Ka therapy
    Badarni, Mai
    Prasad, Manu
    Balaban, Noa
    Zorea, Jonathan
    Yegodayev, Ksenia M.
    Ben-Zion, Joshua
    Dinuri, Anat Bahat
    Grenman, Reidar
    Rotblatc, Barak
    Cohen, Limor
    Elkabets, Moshe
    [J]. JCI INSIGHT, 2019, 4 (08)
  • [7] Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
    Bagchi, Sreya
    Yuan, Robert
    Engleman, Edgar G.
    [J]. ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 16, 2021, 2021, 16 : 223 - 249
  • [8] Intracellular signaling of the Ufo/Axl receptor tyrosine kinase is mediated mainly by a multi-substrate docking-site
    Braunger, J
    Schleithoff, L
    Schulz, AS
    Kessler, H
    Lammers, R
    Ullrich, A
    Bartram, CR
    Janssen, JWG
    [J]. ONCOGENE, 1997, 14 (22) : 2619 - 2631
  • [9] Cross-Phosphorylation, Signaling and Proliferative Functions of the Tyro3 and Axl Receptors in Rat2 Cells
    Brown, Jessica E.
    Krodel, Meredith
    Pazos, Mauricio
    Lai, Cary
    Prieto, Anne L.
    [J]. PLOS ONE, 2012, 7 (05):
  • [10] GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis
    Bruce, Shaina F.
    Cho, Kevin
    Noia, Hollie
    Lomonosova, Elena
    Stock, Elizabeth C.
    Oplt, Alyssa
    Blachut, Barbara
    Mullen, Mary M.
    Kuroki, Lindsay M.
    Hagemann, Andrea R.
    McCourt, Carolyn K.
    Thaker, Premal H.
    Khabele, Dineo
    Powell, Matthew A.
    Mutch, David G.
    Shriver, Leah P.
    Patti, Gary J.
    Fuh, Katherine C.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2022, 21 (08) : 1348 - 1359
12345678910